PubMed:10389937 / 1274-1463 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T9","span":{"begin":0,"end":189},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":189},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"MYCN-amplified tumors expressed lower levels of EPHB6, EFNB2, EFNB3, and TrkA transcripts compared to nonamplified tumors (P = 0.0006, P = 0.0023, P = 0.0048, and P = 0.0001, respectively)."}

{"project":"PubmedHPO","denotations":[{"id":"T6","span":{"begin":15,"end":21},"obj":"HP_0002664"},{"id":"T7","span":{"begin":115,"end":121},"obj":"HP_0002664"}],"text":"MYCN-amplified tumors expressed lower levels of EPHB6, EFNB2, EFNB3, and TrkA transcripts compared to nonamplified tumors (P = 0.0006, P = 0.0023, P = 0.0048, and P = 0.0001, respectively)."}